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ABSTRACT
Objectives: The aim of this study was to assess the reliability,
dimensionality and validity of the self-report questionnaire
Health-Risk Attitude Scale (HRAS-13) in a sample of the general
population and a patient population.
Methods: Sample 1 (n¼ 930) was recruited from the general
population aged 18–65 years in the Netherlands. Sample 2
(n¼ 486) was recruited from the population of knee and hip
osteoarthritis patients aged 45 and over, also from the
Netherlands. Reliability was assessed using Cronbach’s alpha, aver-
age inter-item correlation and item-total correlations.
Dimensionality was examined using confirmatory factor analysis
(CFA), principal component analysis (PCA) and bifactor analysis.
Validity was assessed by performing known-group analysis using
ANOVA tests.
Results: Cronbach’s alphas of the HRAS-13 were 0.73 in sample
1 and 0.69 in sample 2. Reliability and dimensionality analyses dif-
fered slightly between the samples, and suggest that a short ver-
sion of the HRAS may capture a general component of health-risk
attitude. Validity assessment of known groups showed that the
HRAS-13 and a likely HRAS-6 distinguished between subgroups of
respondents based on most of the assessed characteristics, but
not all.
Discussion: These findings are a preliminary indication that the
HRAS-13 is a promising multidimensional instrument for measur-
ing health-risk attitude. However, further research in various sam-
ples on decisions where health risks play a role is warranted to
confirm the dimensionality of the HRAS-13 and the items to be
retained in a full or a shorter version.
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People differ in their attitude towards health risks, and such risk attitudes were shown
to be associated with different unhealthy behaviours (e.g. smoking), preventive behav-
iours (e.g. diet, vaccination, safety) and treatment preferences in the clinic (Dieteren
et al., 2020; Himmler et al., 2020; Lion & Meertens, 2001; Pearson et al., 1995;
Reventlow et al., 2001; Szrek et al., 2012). Therefore, measuring risk attitude in the
context of health and health behaviours in a valid and reliable manner is important.
Several scales exist that can be used to assess general risk attitude (Lion & Meertens,
2001; Pearson et al., 1995; Zhang et al., 2019), but there is no consensus about
whether risk attitude is context dependent (i.e. may differ between life domains), or
whether a general risk trait exists (Dohmen et al., 2011; Frey et al., 2017; Mata et al.,
2018; Slovic et al., 1980; Weber et al., 2002). Weber et al. (2002) argued that risk atti-
tude is stable across domains, but that people may perceive risk differently depending
on the situation or domain. As such, in their Domain-Specific Risk-Taking (DOSPERT)
measure, they make a distinction between risk perception and risk-taking behaviour.
Zhang et al. (2019) tested the context-dependency of risk attitude by developing a
general risk propensity scale and comparing it to the DOSPERT. They developed an
instrument that they consider preferable for predicting broad outcomes in multiple
domains of life, and that shares many characteristics with personality measures, but
also advise that domain-specific measures may be more appropriate when predicting
domain-specific risky behaviour. Dohmen et al. (2011) also found that a general meas-
ure of risk performs very well in terms of predicting risky behaviour, even across con-
texts, but that domain-specific items may provide an even stronger measure in that
particular context. Soane and Chmiel (2005) observed that people vary in whether
their risk preferences are consistent across the domains work, health and finance, and
that personality could influence the stability of preferences. The complexity of the
topic as well as the lack of consensus highlights the importance of further exploring
domain-specific risk attitude scales, with health being an important life domain in
this context.
The availability of validated scales to assess health-related risk attitude is limited.
One potentially useful instrument is the Health-Risk Attitude Scale (HRAS-13), a
13-item scale that aims to measure health-related risk attitude. The HRAS-13 was
developed but its reliability, dimensionality and validity so far were tested only in two
relatively small convenience samples (van Osch, 2007). Therefore, there is a need to
further evaluate the psychometric properties of the Health-Risk Attitude Scale (HRAS-
13) in larger samples and diverse populations.
The scale is context-specific to avoid the need to differentiate between risk-taking
behaviour and risk perception, as argued by Weber et al. (2002). In addition, the
HRAS-13 aims to measure health-risk attitude in a comprehensive manner by including
items about the subdomains medical treatment, the importance of health, general atti-
tude towards risk-taking in health and care, and consideration of the future conse-
quences of health behaviours. This distinguishes it from the Health/Safety subscale of
the DOSPERT, which focusses on preventive health behaviour (Weber et al., 2002).
More information about the motivation for and development and earlier validation of
the HRAS-13 can be found in van Osch (2007).
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Being able to identify differences in risk attitude between individuals and to predict
how a person will resolve risky health decisions may facilitate health research, but also
improve health care practice in several ways. Firstly, patients and health care providers
can benefit from being able to measure risk attitude in clinical practice as it can
explain or predict treatment preferences (Fraenkel et al., 2003; Pearson et al., 1995;
Prosser et al., 2002), and it can enhance risk communication and shared decision mak-
ing (Elwyn et al., 2004). Secondly, being able to distinguish individuals based on their
health-risk attitude allows for more tailored policy making in sectors like health insur-
ance (Wagstaff & Lindelow, 2008). Moreover, knowing individuals’ health-risk attitude
might lead to improved prediction of how society will respond to public health inter-
ventions regarding for example vaccination (Brewer et al., 2004) and pandemics such
as COVID-19 in which risk perception, attitude and behaviour are crucial for prevention
and containment of a virus (Chan et al., 2020; Cori et al., 2020). Also, given the increas-
ing interest in the HRAS (Bansback et al., 2016; Dieteren et al., 2020; Himmler et al.,
2020), this paper aims to investigate the reliability, dimensionality and validity of the
HRAS-13 in two larger samples, one sample from the general population and one sam-
ple from a patient population, both from the Netherlands.
Methods
Data collection
For the purpose of this study, we use available data collected in two separate studies.
Respondents in both studies were informed about the purpose of the study and the
anonymity of their data, and all respondents included in this study gave informed con-
sent for using their responses for academic purposes. The 13 items of the HRAS-13
(included in Table 5) are rated on a seven-point Likert scale from ‘completely disagree’
to ‘completely agree’. Total scores for the HRAS-13 are obtained by summing the
scores to each item, where items 1, 3, 4, 5, 9, 10 and 12 are reverse-scored because of
their phrasing. A higher sum-score on the HRAS-13 corresponds to a more positive
attitude towards health risks.
Sample 1 concerns a randomly stratified sample from the population aged
18–65 years in the Netherlands according to age, gender and level of education.
Respondents were recruited through a survey company and the data were collected
online in 2010, in the context of a larger study investigating health state valuations
(van Nooten et al., 2015), acceptability of less than perfect health ates (Wouters et al.,
2015), and expectations about longevity and quality of life at older age (Rappange
et al., 2016). A small sum was donated to a charity of the respondent’s choice as
reward for participation. Respondents also answered questions about socio-demo-
graphic characteristics, their health and happiness levels, and health behaviour.
Behavioural variables were categorised into healthy or unhealthy behaviour according
to national guidelines, as in Rappange et al. (2016). Smoking behaviour was categor-
ised as no or yes. Nutrition was categorised as eating a variety of foods at least 6 days
a week according to the Dutch norms for healthy nutrition or less than the norm.
Alcohol consumption was categorised as ‘no’ if respondents did not drink, moderate if
they drank occasionally, or ‘heavy/excessive’ if alcohol consumption exceeded 21
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drinks per week for males or 14 drinks per week for females. Physical exercise was cat-
egorised (using Dutch health norms) based on whether respondents exercised at least
30minutes a day on at least 5 days a week or less than that. Health was measured
using a visual analogue scale ranging from 0 (worst imaginable health state) to 100
(best imaginable health state), while happiness was measured using a scale ranging
from 0 (completely unhappy) to 100 (completely happy).
Sample 2 consists of knee and hip osteoarthritis patients aged 45 and over, and
was recruited by a survey company. Data were collected online in 2019 as part of a
study about health preferences of patients with knee or hip osteoarthritis (Arslan
et al., 2020). All respondents received a financial compensation for their time invest-
ment. Respondents also answered questions about socio-demographic characteristics
and their health status, also using a visual analogue scale ranging from 0 (worst
imaginable health state) to 100 (best imaginable health state).
Sample and descriptive statistics
A total of 1,223 respondents completed the questionnaire in sample 1. Because it was
a lengthy questionnaire and administered online, basic speeding and response pattern
analysis were conducted in order to remove potentially poor-quality data. This resulted
in exclusion of 156 respondents (12.8%) from the sample on the basis of speeding
through the questionnaire (<15minutes completion time) and another 137 respond-
ents (11.2%) because they had eight or more identical item values on the HRAS-13.
The final sample for analysis therefore consisted of 930 observations (76.0%). In sam-
ple 2, a total of 648 respondents completed the questionnaire. As in sample 1, speed-
ing (duration <8minutes) and response pattern analysis (8 identical item values on
HRAS-13) were performed leading to an exclusion of 85 (13.1%) and 74 respondents
(11.4%), respectively. The final sample consisted of 489 respondents (75.5%).
An overview of the descriptive statistics of the HRAS-13 in both samples can be
found in Table 1. Sample 1 had a mean HRAS score of 44.5, a standard deviation of
9.9, the median was 44.0 and scores ranged between 15 and 84. In sample 2, the
mean and median were slightly higher (48.8 and 49.0, respectively), the standard devi-
ation was lower (5.6) and the range was smaller (29–65). In sample 1, the data are
right skewed (0.239) with a kurtosis of 0.234. In sample 2, the HRAS scores were
slightly left skewed (0.277) with a higher kurtosis of 0.500. Figure 1 shows the scor-
ing pattern per item of raw HRAS-13 scores (i.e. before reverse-scoring) in
both samples.
Sample characteristics are described in Table 2. In sample 1, 30.1% of respondents
were between 16 and 35 years old, 33.7% between 36 and 50 and another 36.2% was
older than 50. Gender was almost equally distributed, and most respondents had a
partner (64.4%). In terms of education, 14.1% had completed low level education,
53.7% middle level, and 32.3% high level education. In sample 2, respondents were
included as of 45 years and older. Hence, 10.0% was in the category between 36 and
50 and the large majority of respondents (90.0%) were between 51 and 90 years old.
This sample contained slightly more females (56.4%) and somewhat lower educated
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respondents (30.7% low, vs. 42.9% middle, 26.0% high and 0.4% other) than the
first sample.
Reliability
Reliability of the HRAS-13 was assessed by calculating internal consistency (i.e.
Cronbach’s alpha), average inter-item correlation and item-total correlations in both
samples. We also examined whether removing one of more of the items would lead
to an increase of these statistics and hence to a better reliability.
Dimensionality
To assess the dimensionality of the HRAS-13, factor analyses were performed in both
samples. To validate the one-factor structure introduced by van Osch (2007),
Confirmatory Factor Analysis was performed first. The Confirmatory Fit Index (CFI),
Root Mean Square Error of Approximation (RMSEA) and Standardized Root Mean
Square Residual (SRMR) of the one-factor model were compared to their cut-off values
to assess model fit (Hu & Bentler, 1999). As the Confirmatory Factor Analysis (CFA)
could not confirm the existing factor structure, Principal Component Analysis (CFA)
using varimax rotation was performed as in van Osch (2007) to assess the factor
Table 1. Descriptive statistics HRAS-13 in samples 1 and 2
Result Sample 1 Sample 2
Total N 930 489






Figure 1. Scoring pattern HRAS-13 scores
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structure. In addition, bifactor analysis was conducted to assess potential multidimen-
sionality and to test for the existence of a general component and specific sub-factors
in health-risk attitude.
Validity
To assess the validity of the HRAS-13, known-group validity was examined. T-tests and
ANOVA tests were used to analyse whether groups with different age, gender and
marital status as well as groups with varying health behaviours (i.e. smoking, nutrition,
alcohol and physical exercise) and general health and happiness showed different
HRAS-13 scores. It is hypothesised that there is a negative relationship between the
HRAS-13 and age (Dohmen et al., 2011), being female (Dohmen et al., 2011; Weber
et al., 2002) and having a partner (Dohmen et al., 2011), hence expecting that these
subgroups in the data are more health-risk averse. Based on literature concerning gen-
eral rather than health-specific risk attitude, individuals with a higher education are
expected to be more risk seeking (Donkers et al., 2001; Schurer, 2015). Following
Table 2. Sample characteristics and results ANOVA tests between known groups (validity)
Characteristic
Sample 1 Sample 2
N (%)
Mean score
HRAS-13 p N (%)
Mean score
HRAS-13 p
Agea 16–35 years 280 (30.1) 44.9 n.s. 0 (0.0) — n.s.
36–50 years 313 (33.7) 44.9 49 (10.0) 48.6
51–90 years 337 (36.2) 43.6 440 (90.0) 48.8
Gender Female 466 (50.1) 42.8  276 (56.4) 48.3 
Male 464 (49.9) 46.2 213 (43.6) 49.5
Education level Low 131 (14.1) 42.7 n.s. 150 (30.7) 48.8 n.s.
Middle 499 (53.7) 44.8 210 (42.9) 49.3
High 300 (32.3) 44.7 127 (26.0) 48.0
Other — — 2 (0.4) 45.5
Partnerb No 304 (32.7) 45.9  — — —
Yes 599 (64.4) 43.7 — — —
Smoking No 576 (61.9) 42.3  — — —
Yes 354 (38.1) 48.1 — — —
Nutrition  norm 445 (47.8) 42.6  — — —
<norm 485 (52.2) 46.2 — — —
Alcohol No 331 (35.6) 43.4  — — —
Moderate 492 (52.9) 44.0 — — —
Heavy/excessive 107 (11.5) 49.6 — — —
Physical exercise Norm 473 (50.9) 43.4  — — —
<Norm 457 (49.1) 45.5 — — —
Healtha <70 255 (27.4) 46.5  206 (42.1) 49.4 n.s.
70–79 211 (22.7) 45.5 101 (20.7) 48.4
80–89 280 (30.1) 43.7 107 (21.9) 48.4
90 184 (19.8) 41.7 75 (15.3) 48.0
Happinessa <70 237 (25.5) 46.4  — — —
70–79 202 (21.7) 45.8 — — —
80–89 285 (30.6) 43.9 — — —
90 206 (22.2) 41.8 — — —
Notes: Levels of statistical significance: p < .01; p < .05.
aCategories of subgroups for age, health and happiness were established so that each category contained an equal
number of respondents in sample 1, cut-off points were rounded off to the nearest multiple of 5.
bIn sample 1 n¼ 903 (27 missing values; 2.9%).
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literature in which health behaviour is associated with risk attitude (Anderson &
Mellor, 2008; Beauchamp et al., 2017; Dieteren et al., 2020; Dohmen et al., 2011;
Weber et al., 2002), it is expected that HRAS-13 scores are positively associated with
unhealthy behaviours (i.e. smoking, poor nutrition, excessive drinking and limited
physical exercise) of respondents. Furthermore, based on literature about general risk
measures and health and happiness, a negative relationship is expected between the
HRAS-13 and health (Courbage et al., 2017; Decker & Schmitz, 2016) and happiness
(Guven, 2012; Guven & Hoxha, 2015; Nguyen & Noussair, 2014). As can be seen in
Table 3, all these variables were collected in sample 1 but fewer variables were col-
lected in sample 2. Hence, for the second sample we could only test gender, educa-
tion level and health.
Results
Reliability
As can be seen in Table 3, Cronbach’s alpha of the HRAS-13 scale in sample 1 was
0.73, indicating acceptable internal consistency. Cronbach’s alpha could be increased
up to 0.84 by removing seven items (i.e. 13, 8, 12, 4, 2, 6 and 11). Removing any add-
itional items would no longer lead to an increase in Cronbach’s alpha. In sample 2,
internal consistency was slightly lower than in sample 1 (Cronbach’s alpha 0.69) but
could be increased to 0.82 by removing eight items (i.e. 8, 13, 12, 2, 6, 11, 4 and 7).
These are largely the same items as identified for removal in sample 1 but removed in
a slightly different order. The only other -and additional- item excluded in sample 2
was item 7. In addition, based on average inter-item correlations and item-total corre-
lations and a cut-off correlation for retention of 0.3, items 8, 12 and 13 should poten-
tially be removed (see suppporting information Tables A1 and A2); the reliability of
the HRAS-13 could be further improved by removal of additional items. These are
largely the same items as based on the Cronbach’s alpha.
Dimensionality
Confirmatory Factor Analysis (CFA) was performed to examine the previously deter-
mined one-factor structure of the HRAS-13. The results are presented in Table 4. In
sample 1, the Comparative Fit Index was 0.78, the Root Mean Square Error of
Approximation (RMSEA) was 0.10 and the Standardized Root Mean Square Residual
Table 3. Cronbach’s alpha analysis (reliability)
Sample 1 Sample 2
Order of removing items Cronbach’s alpha Order of removing items Cronbach’s alpha
Starting alpha 0.732 Starting alpha 0.693
HRAS13 0.755 HRAS8 0.725
HRAS8 0.780 HRAS13 0.746
HRAS12 0.801 HRAS12 0.765
HRAS4 0.805 HRAS2 0.778
HRAS2 0.810 HRAS6 0.796
HRAS6 0.823 HRAS11 0.803
HRAS11 0.836 HRAS4 0.808
– HRAS7 0.817
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(SRMR) was 0.07. Based on these statistics the model fit is not good, and a one-factor
model does therefore not seem accurate. In sample 2, the CFI was 0.65, the RSMEA
and the SRMR were 0.13 and 0.09, respectively. Therefore, the one factor model per-
formed worse in sample 2 than in sample 1. We subsequently performed a Principal
Component Analysis (PCA) to explore multidimensionality. As can be seen in Figure 2,
in sample 1 the first three components had an eigenvalue above one. Hence, a three-
factor model was identified with the cumulative proportion of variance explained
being 26%, 44% and 52%, respectively. In sample 2, four factors had an eigenvalue
Table 4. Confirmatory factor analysis and bifactor analysis (dimensionality)
Fit index Sample 1 Sample 2
Confirmatory factor analysis – one factor
Comparative fit index 0.778 0.645
Root mean square error of approximation 0.102 0.128
Standardised root mean square residual 0.074 0.091
Bifactor analysis – three factors
Root mean square error of approximation 0.061 0.089
Table 5. Principal component analysis (dimensionality)
No. Item
Sample 1 Sample 2
PC 1 PC2 PC3 PC 1 PC2 PC3
1 I think that I take good care of
my body.
0.679 0.628
2 I don’t want to have to consider the
consequences for my health in
everything that I do.
0.549
3 It is important for me to organise
my life in a way that will benefit
my health later on.
0.791 0.740
4 When it comes to my health, I
consider myself a risk avoider.
0.507
5 My health means everything to me. 0.774 0.780
6 Looking back at my past, I would
say that I have generally taken
risks with my health.
0.742 0.742
7 I don’t worry too much about my
health in what I do.
0.523 0.562 0.704
8 Uncertainty about the consequences
of a medical intervention is, in
general, part of the deal.
9 Safety has priority where my
health’s concerned.
0.777 0.774
10 To ensure good health now and
later, I am prepared to forego a
lot of things.
0.648 0.760
11 People say that I take risks with my
health because of my habits.
0.719 0.829
12 If the doctor can’t give me
assurances about the possible
consequences of a medical
intervention, then I’d rather not
have it.
0.504 0.682
13 In general, I would estimate that I
would not have much of a
problem with undergoing a high
risk operation.
0.802 0.771
Cumulative proportion of variance explained 26% 44% 52% 25% 41% 53%
Note: ‘’ indicates item was reverse-scored in analysis. Only factor loadings >0.50 are presented.
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above one (Figure 3). However, because the eigenvalue of the fourth factor was only
marginally above one and for comparability with sample 1, also in this sample a
three-factor model was specified. Here, the cumulative proportion of variance
explained was 25%, 41% and 53%, respectively. The results of these three-factor mod-
els are presented in Table 5. In sample 1, the six items 1, 3, 5, 7, 9 and 10 loaded on
the first factor (>0.50). Except for item 7, these items were phrased positively, express-
ing risk aversion, and were reverse-scored in the analysis. Items 2, 6, 7 and 11 loaded
on the second factor (>0.50). These items were all phrased negatively as opposed to
Figure 2. Scree plot sample 1
Figure 3. Scree plot sample 2
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most items loading on the first factor. Items 12 and 13 loaded on the third factor
(>0.50). Items 4 and 8 had factor loadings lower than 0.5 on all factors. Based on the
items that loaded strongly on the first factor, this factor can be described as the
degree to which health-risks play an important and active role in peoples’ lives. The
second factor can be described as health-risks that are perceived to be only implicitly
and indirectly related to peoples’ lives, i.e. indirect health-risk attitude and uninten-
tional health behaviour. The third factor specifically related to attitude towards risks
related to medical treatments. The results of the PCA in the second sample were
largely similar (see Table 5). The items generally loaded on the same factors as in sam-
ple 1 but there was some variation in the strengths of the loadings. Item 4 now
loaded on factor 1, while item 2 no longer loaded on factor 2 and item 7 no longer
on factor 1 (<0.5).
Exploratory bifactor models with three factors were estimated in both samples, rep-
licating the number of factors found in the PCA. In both bifactor models we found
that the RMSEA statistics were smaller (0.061 and 0.089) than in the one-factor CFA
(0.102 and 0.128), indicating a better model fit when accounting for multidimensional-
ity of the HRAS (see Table 4). The models show that there appears to be a general fac-
tor, with items 1, 3, 4, 5, 7, 9, 10 and 11 loading on this factor (>0.3) in sample 1, and
the same items except for item 4 in sample 2 (see Figures 4 and 5). In addition, in
sample 1 there is one and in sample 2 there are two sub-factors consisting of items
that do and do not load on the general factor; in both samples there is a third factor
consisting of items not loading on the general factor. Some of the items do not load
on the general factor nor on any of the sub-factors. A concurrent finding from the dif-
ferent reliability and dimensionality analyses in these two samples is that a short ver-
sion of the HRAS, in any case including the items 1, 3, 5, 7, 9 and 10, may capture a
general component of health-risk attitude.
Validity
Despite the fact that the aforementioned analyses indicate that the HRAS-13 likely is
not unidimensional and that some of the current 13 items may be redundant, the
analyses did not point towards an unambiguous break-down of the measure into
dimensions or reduction in the number of items. Hence, in this first validation study of
the HRAS-13, we here present results for the validity of the 13-item measure as origin-
ally proposed (van Osch, 2007) and previously used in the literature (Bansback et al.,
2016; Dieteren et al., 2020; Himmler et al., 2020). Results (only tables) for the validity
of a likely 6-item short version consisting of the items 1, 3, 5, 7, 9 and 10 are pre-
sented in the suppporting information (see appendix, Tables A3 and A4).
Female respondents on average had a statistically significant lower HRAS-13 score
than males in both samples (see Table 2). Only sample 1 contained information about
whether respondents had a partner; respondents with a partner were found to have
lower HRAS-13 scores. In neither of the samples a statistically significant relationship
was found with age or education level. On average, respondents engaged in
unhealthy behaviours had higher HRAS-13 scores (in sample 1). Smokers had a sub-
stantially higher HRAS-13 score than non-smokers. Respondents who did not meet the
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norm for eating healthily had a significantly higher HRAS-13 score than those who
did. Heavy drinkers had a higher HRAS-13 score than those who drank moderately or
not at all. Respondents who exercised regularly had a lower HRAS-13 score than those
who did not. HRAS-13 scores were negatively associated with health and happiness
scores in sample 1. In sample 2, health-risk attitude was similarly associated with gen-
der, but not significantly associated with health (the other variables were not available
for this sample). The results of the mean HRAS-13 scores of different subgroups are
summarised in Table 2.
Discussion
The aim of this paper was to assess the psychometric properties of the HRAS-13 in
terms of reliability, dimensionality and validity in a sample from the general popula-
tion and a sample from a patient population. Respondents in the patient sample
(n¼ 489) had a higher mean HRAS-13 score than respondents in the general popula-
tion sample (n¼ 930), indicating that the patient sample generally had a more positive
attitude towards health risks, or was more health-risk seeking. HRAS-13 scores were
also less widespread in the rather homogeneous patient sample.
Reliability—examined using the Cronbach’s alpha as a measure for internal consist-
ency—was higher in the general population sample (sample 1) than in the patient
sample (sample 2). In the first sample, Cronbach’s alpha could be increased from 0.73
to 0.84 by removing seven of the thirteen items, leaving a scale of six items consisting
of 1, 3, 5, 7, 9 and 10. In the second sample, internal consistency (Cronbach’s alpha of
0.69 in HRAS-13) could be increased by removing eight items, that is, the same seven
items as in sample 1 (Cronbach’s alpha of 0.81) and item 7 (Cronbach’s alpha of 0.82).
In addition, based on average inter-item correlations and item-total correlations items
8, 12 and 13 should potentially be removed. The reliability of the HRAS-13 could be
Figure 4. Bifactor model sample 1
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further improved by removal of additional items in largely the same order as shown in
the Cronbach’s alpha analysis. These results indicate that the reliability of the scale
could be improved if items are removed from the scale, which would also reduce
respondent burden.
The one-factor model found by van Osch (2007) was not confirmed in these sam-
ples (CFA). Instead, using Principal Component Analysis a three-factor structure was
specified for both samples, with the items loading similarly on the three factors in
each sample. The factor loadings indicated that the first factor can be described as the
degree to which health-risks and attitude towards it play an important role in peoples’
lives. The second factor was characterised by items that described indirect health-risk
attitude and unintentional health behaviour. The third factor specifically related to atti-
tude towards risks involved in medical treatment. These dimensionality results indicate
that health-risk attitude as measured by the HRAS-13 in these two samples likely is a
multidimensional concept. The bifactor analyses in both samples confirmed the multi-
dimensionality of the HRAS-13 and the potential redundancy of some of its items. The
items loading on the first factor in the PCA and the general factor in the bifactor ana-
lysis largely corresponded to those that were retained in the reliability analysis, while
the items loading on the second and third factor corresponded to those that were
removed in order to increase Cronbach’s alpha. Considering that the results of the reli-
ability and dimensionality analyses differed between the two samples, one of which is
a general public sample and the other a specific patient sample, we see these results
as a preliminary indication that the HRAS-13 is a multidimensional scale, with some of
the current 13 items possibly contributing to a general factor, some only to a specific
sub-factor, and some items perhaps being redundant. A concurrent finding from the
different analyses in both samples is that a short version of the HRAS including (at
least) the items 1, 3, 5, 7, 9 and 10 may capture a general component of health-risk
attitude. However, further studies are required to confirm the dimensionality of the
HRAS-13 and the items to be retained in a full or a shorter version. Moreover,
Figure 5. Bifactor model sample 2
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although here risk attitude was only measured in the domain of health, the factor
structures observed support the multidimensionality of risk attitude also within this
domain, and is a preliminary indication that domain-specific variance may exist, in
addition to a general risk attitude component (Frey et al., 2017; Weber et al., 2002). To
provide more conclusive evidence on the relative importance of general and domain-
specific risk attitude, in future studies the HRAS-13 should also be compared to a
measure of general risk attitude.
In the assessment of known-groups validity we found that the HRAS-13 was associ-
ated in the expected direction with various sample characteristics. In general, females
(both samples) and people with a partner (only measured in sample 1) reported a sig-
nificantly lower HRAS-13 score than their counterparts. Contrary to our expectation, no
relationship was found with age nor education. Looking at the mean HRAS-13 scores
per age group in sample 1, there might be a non-linear relationship between the vari-
ables that is not identified by ANOVA tests. The expectation that education was
related to risk attitude was based on the literature about general risk-attitude rather
than health-specific. As measured in sample 1, respondents engaged in unhealthy
behaviours (i.e. smoking, poor nutrition, excessive drinking and limited physical exer-
cise) generally reported higher HRAS-13 scores. These findings are much in line with
our expectations based on previous literature. The results for sample 1 also show that
healthier and happier respondents had lower HRAS-13 scores. No association was
found between health-risk attitude and health in sample 2. Overall, these correlations
show that the HRAS-13 can distinguish between subgroups of respondents based on
the observable characteristics gender, having a partner, health behaviour and health
and happiness in a sample from the general population. In the patient sample, HRAS-
13 scores differed by gender but not by health. The latter could be because people in
the patient population were generally in poorer health. Analysis of known-group valid-
ity of the HRAS-6 showed some additional statistically significant associations. Older
people were found to have lower HRAS-6 scores in both samples, the same holds for
healthier people in sample 2. However, females no longer had statistically significant
different HRAS-scores from those of males in sample 2. Other associations were similar
to HRAS-13 scores.
Studying the performance of the HRAS-13 in samples from the general population
and a specific patient population in relation to several outcome measures and behav-
iours is a strength of this research. The scale was originally developed based on infor-
mation from patients and experts, and now its reliability, dimensionality and validity in
two large samples from the general and a patient population were assessed. Results
of reliability and dimensionality were largely similar in both samples. Regarding valid-
ity, some differences were found. These similarities and differences in results across
samples also warrant caution in interpreting results. Firstly, this study contained one
sample of the general population and one relatively homogenous patient population.
Although we found quite similar results in both samples, it should be investigated fur-
ther whether elements of risk attitude of the general public (e.g. in relation to preven-
tion and health behaviour) are sufficiently captured in the HRAS-13, and whether
results are also similar in other patient samples. Secondly, the HRAS involves stated
preferences which might not always be a good predictor of revealed preferences and
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behaviour, and vice versa (Bradley & Daly, 1997; Charness et al., 2020; Frey et al., 2017;
King & Bruner, 2000; List & Gallet, 2001; Mata et al., 2018; Murphy et al., 2005). As
such, it is recommended to study the performance of the HRAS-13 in a context where
data about revealed health behaviour (e.g. treatment choices, adherence to guidelines)
is available. Furthermore, both studies were conducted in the Netherlands, which
potentially limits the generalisability of the findings. Within a Canadian sample,
Bansback et al. (2016) reported that women were more risk averse than men, which is
similar to our findings. However, they also reported an association between HRAS-13
scores and age, which was not observed in our studies. For a broader applicability of
the HRAS-13 and understanding of the results in different settings, future research of
the reliability and validity of the HRAS-13 in samples of the general population as well
as a variety of patient populations and in multiple countries is encouraged. In add-
ition, the relatively newer DOSPERTþM, an additional subscale of the DOSPERT that
focuses on risk related to healthcare activities, was not included here as it was not
included in the data available for this study (Butler et al., 2012; Rosman et al., 2013;
Schwartz et al., 2013). It would be interesting for future research to compare the
HRAS-13 with the DOSPERTþM (and the health/safety subscale) in the context of pre-
ventive health behaviours and treatment decisions. Lastly, to remove possibly poor-
quality data, about a quarter of respondents were excluded based on speeding and
response pattern analysis in both samples. Excluded respondents were mostly male
and younger than the remainder of the samples, they were of similar education level
and had higher HRAS-13 scores than the included respondents. When performing the
reliability, dimensionality, and validity analyses with the full sample, results remained
largely the same. In terms of reliability, Cronbach’s alpha would have been lower if
the full samples were used. Regarding dimensionality, a one-factor structure would
again not be confirmed in the full samples, and a three-factor model was identified
instead. The expected relationship between HRAS-13 scores and age between would
have been statistically significant in the full sample 1. This could be explained by the
fact that exclusion was slightly selective in terms of gender and age.
In conclusion, this psychometric evaluation has shown that further study is neces-
sary into the reliability, dimensionality and validity of the HRAS-13 as a measure of risk
attitude in the health domain. The results showed that internal consistency of the
scale would be higher if some items are excluded. However, based on the dimension-
ality results, this would also mean excluding indirect health-risk attitude and behavior
and attitude towards medical treatment risks. Depending on the context in which the
instrument is used, studying the validity of a shorter version of the HRAS representing
a general component of health-risk attitude could be relevant, both in terms of its
psychometric properties as in reducing respondent burden. Certain dimensions (or
sub-factors), as for example the one determined by the items 8, 12 and 13 relating to
the risks associated with medical treatments, may be more relevant in specific popula-
tions or contexts. Nonetheless, the ability of the HRAS-13 and the HRAS-6 to discrimin-
ate between a number of different subgroups based on socio-demographics and
health behaviours, makes that, awaiting further validation, these versions of the meas-
ure can already be used in a descriptive and predictive manner for individuals as well
as for groups of individuals. Hence, the HRAS-13 can inform patients and health care
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providers about treatment preferences, and the HRAS-6 can inform members of the
public, public health practitioners and policy makers about the general attitude of
people towards risk taking in the health domain. More studies, both in large represen-
tative samples of the general public as in a variety of patient samples and healthcare
contexts are required before these versions of the HRAS can be applied to inform pol-
icy decisions such as healthcare priority setting and health insurance, and decisions
about public health in terms of for example prevention of diseases, promotion of a
healthier lifestyle, or adherence to treatment guidelines and precautionary health
safety measures in times of a pandemic. Next steps are to adopt and test the scale in
varying health-risk contexts in medical decision making, and to further research the
usefulness of the HRAS-13 in research and practice.
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